Position in AXGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$32,667,138
+$25,099,021 QoQ
Shares Held
707,234
+209.6% QoQ
Ownership
1.32%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#23
of 250 holders
Holding Since
Jun 2021
6 quarters on record
Voting authority
Sole 78%
Shared 0%
None 22%
Common Shares in AXGN Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Driehaus Capital Management LLC holds $245,160,540 across 7 Medical Devices names. AXGN ranks #3 (13.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GKOS |
GLAUKOS Corp
|
650,571 | $90,923,802 | |
| 2 | LIVN |
LivaNova PLC
|
516,086 | $42,437,751 | |
| 3 | AXGN |
Axogen, Inc.
This page
|
707,234 | $32,667,138 | |
| 4 | TCMD |
Tactile Systems Technology Inc
|
937,783 | $27,927,177 | |
| 5 | TNDM |
Tandem Diabetes Care Inc
|
1,786,996 | $26,965,769 | |
| 6 | NPCE |
NeuroPace Inc
|
1,447,391 | $22,999,042 | |
| 7 | CERS |
Cerus Corp
|
424,610 | $1,239,861 |
All Filings in AXGN
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $32,667,138 | 707,234 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $7,568,117 | 228,437 | Shares | Sole | 2026-05-15 | |
| 2025-03-31 | $21,682,536 | 1,172,029 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $15,729,154 | 954,439 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $5,031,217 | 358,860 | Shares | Sole | 2024-11-14 | |
| 2021-06-30 | $6,703,141 | 310,187 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||